NEW TRENDS IN CLASSIFICATION, MONITORING AND MANAGEMENT OF METABOLIC SYNDROME

Under the Auspices of IFCC 

Edited by
Prof. Elizabeta Topić, Ph.D.
Pika Me�ko Brguljan Ph.D.
Prof. Victor Blaton, Ph.D.

Organizers
Croatian Society of Medical Biochemists
Slovenian Association for Clinical Chemistry
Forum of the European Societies of Clinical Chemistry
and Laboratory Medicine
Dubrovnik, November 11-12, 2006

Table of contents

EDITIORIAL

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME 
 Prof. Izet Aganović, MD, Ph.D; Tina Du�ek, MD

2. GENETIC SUCCEPTIBILITY TO METABOLIC SYNDROME 
 Prof. Janja Marc, Ph.D.

3. HOW IS THE METABOLIC SYNDROME RELATED TO THE DYSLIPIDEMIA? 
 Prof. Victor Blaton, Ph.D.

4. CORONARY DISEASE AND METABOLIC SYNDROME 
 Prof. G�bor L. Kov�cs, MD, Ph.D.

5. INSULIN RESISTANCE AND METABOLIC SYNDROME 
 Prof. Istv�n Wittmann, MD, Ph.D.

6. PRO-INFLAMMATORY AND PROTHROMBOTIC FACTORS AND METABOLIC SYNDROME 
 Prof. Grazyna Sypniewska, Ph.D.

7. EVIDENCE BASED LABORATORY MEDICINE IN THE DIAGNOSIS OF METABOLIC SYNDROME 
 Prof. Ana Stavljenić � Rukavina, Ph.D.; Daria Pa�alić, Ph.D.

8. HYPERTENSION AND THE METABOLIC SYNDROME 
 Assist. Prof. Lea Duvnjak, MD, Ph.D.

9. APPROACH TO THE TREATEMENT OF METABOLIC SYNDROME 
 Prof. Izet Aganović,MD, Ph.D.; Tina Du�ek, MD